# CT Scan Guide Percutaneous Biopsy of Lytic Bone Metastases of Lung Cancer : Contribution in Pathology Diagnosis and Molecular Biology

> **NCT03386916** · — · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 80 (actual)

## Conditions studied

- Image-Guided Biopsy - Carcinoma, Bronchogenic / Diagnosis- Outpatients

## Interventions

- **PROCEDURE:** CT scan guide percutaneous biopsy of lytic bone metastases of lung cancer

## Key facts

- **NCT ID:** NCT03386916
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2017-06
- **Final completion:** 2018-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03386916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03386916, "CT Scan Guide Percutaneous Biopsy of Lytic Bone Metastases of Lung Cancer : Contribution in Pathology Diagnosis and Molecular Biology". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT03386916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*